Loading…
Genenta Science S.p.A. is projected to rise to $1.62 by 2027, a +8% move from its current price of $1.50. GNTA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.41 | $1.50 | $1.59 | -0.07% |
| Jul 14 | $1.38 | $1.50 | $1.63 | -0.14% |
| Jul 15 | $1.35 | $1.50 | $1.66 | -0.22% |
| Jul 16 | $1.33 | $1.50 | $1.68 | -0.29% |
| Jul 17 | $1.31 | $1.49 | $1.70 | -0.36% |
| Jul 18 | $1.30 | $1.49 | $1.72 | -0.43% |
| Jul 19 | $1.28 | $1.49 | $1.74 | -0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.28 | $1.49 | $1.74 | -0.50% |
| Week 2 | $1.19 | $1.48 | $1.85 | -1.00% |
| Week 3 | $1.13 | $1.48 | $1.93 | -1.50% |
| Week 4 | $1.08 | $1.47 | $2.00 | -1.99% |
| Week 5 | $1.04 | $1.46 | $2.06 | -2.48% |
| Week 6 | $0.9987 | $1.46 | $2.12 | -2.97% |
| Week 7 | $0.9641 | $1.45 | $2.18 | -3.46% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Genenta Science S.p.A. is a clinical-stage biotechnology company that develops hematopoietic stem cell gene therapies for solid tumors in Italy. Its Temferon program is in Phase 1/2a clinical trials for glioblastoma multiforme in patients with unmethylated MGMT gene promoter, and the company is developing Temferon for use in other solid tumor indications.
Genenta Science S.p.A. also develops a biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
Genenta Science S.p.A. (GNTA) is currently trading at $1.53 with a market capitalization of $36.09M and a market rank of 4694. The price outlook shows a path of modest to meaningful upside over the forecast horizon, with the avg price rising from $1.53 in 2026 to higher levels in later years and bullish sentiment emerging in the 2030s.
The projected ROI ranges from 0% in 2026 to 276.4% by 2050.
A major floor 84.9% below — a decisive break under it would weaken the trend.
The nearest floor, 40.3% below — buyers have tended to step in here.
The nearest ceiling, 46.7% above — a clean break opens room to run.
A major ceiling 89.1% above — clearing it would confirm fresh momentum.
Key GNTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GNTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.58 | Sell | $1.58 | Sell |
| MA 10 | $1.68 | Sell | $1.65 | Sell |
| MA 20 | $1.76 | Sell | $1.65 | Sell |
| MA 50 | $1.30 | Buy | $1.43 | Buy |
| MA 100 | $1.04 | Buy | $1.33 | Buy |
| MA 200 | $1.55 | Sell | $1.67 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.51 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -167.07 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -18.48 | Sell |
| Bollinger %B (20,2) | -0.03 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 1.24 | Buy |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 27.32 | Buy |
| Momentum (10) | -0.23 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 1.50 | Buy |
| ADX (14) | 18.98 | Neutral |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is NEUTRAL, with RSI(14) at 50.0 and key moving averages near the price: SMA50 is $1.27 and SMA200 is $1.56. Nearby support sits at $0.597 and resistance at $2.20, suggesting a wide but defined trading band. The 30-day range runs from $1.03 to $2.27, and annualized volatility is 100%.
These indicators point to a balanced near-term stance, with room for movement if momentum shifts toward the resistance level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.58 | $1.50 | $1.78 | 0% | Neutral | |
| $1.17 | $1.62 | $2.41 | +8% | Neutral | |
| $1.06 | $1.56 | $2.48 | +4% | Neutral | |
| $0.8958 | $1.38 | $2.30 | -8% | Neutral | |
| $0.9192 | $1.49 | $2.58 | -1% | Neutral | |
| $0.9322 | $1.58 | $2.83 | +5% | Neutral | |
| $1.24 | $2.19 | $4.06 | +46% | Bullish | |
| $1.42 | $2.60 | $4.96 | +74% | Bullish | |
| $1.32 | $2.51 | $4.90 | +67% | Bullish | |
| $1.32 | $2.63 | $5.25 | +75% | Bullish | |
| $1.98 | $4.40 | $9.66 | +193% | Bullish | |
| $2.42 | $5.37 | $12.35 | +258% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.58 | $1.50 | $1.86 | +0.00% |
| August 2026 | $1.19 | $1.44 | $1.82 | -4.04% |
| September 2026 | $1.14 | $1.40 | $1.81 | -2.39% |
| October 2026 | $1.16 | $1.44 | $1.89 | +2.79% |
| November 2026 | $1.11 | $1.40 | $1.86 | -3.06% |
| December 2026 | $1.04 | $1.32 | $1.78 | -5.57% |
Click any year to see its month-by-month GNTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The GNTA price prediction for 2026 points to an average of $1.50 (low $0.58, high $1.78) — a potential gain of 0% on today's $1.50. A consolidation phase looks the most probable path here.
In 2027, GNTA is projected to trade between $1.17 and $2.41, averaging $1.62 — a potential gain of +8% from today's $1.50. That is up +8% on the projected 2026 average. Price action looks broadly range-bound.
Genenta Science S.p.A.'s 2028 outlook centres on $1.56, within a $1.06 to $2.48 range. That is -4% versus the projected 2027 average. That marks a +4% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, GNTA could reach as high as $2.30, with a base case around $1.38 and support toward $0.8958 — roughly -8% from $1.50. Price action looks broadly range-bound.
Expect GNTA to range from $0.9192 to $2.58 through 2030. The $1.49 average target implies a -1% move from current prices. That is up +8% on the projected 2029 average. A consolidation phase looks the most probable path here.
The GNTA price prediction for 2031 points to an average of $1.58 (low $0.9322, high $2.83) — a potential gain of +5% on today's $1.50. Price action looks broadly range-bound.
In 2032, GNTA is projected to trade between $1.24 and $4.06, averaging $2.19 — a potential gain of +46% from today's $1.50. That is up +39% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Genenta Science S.p.A.'s 2033 outlook centres on $2.60, within a $1.42 to $4.96 range. That is up +19% on the projected 2032 average. That marks a +74% change versus current levels. Momentum favours further upside here.
By 2034, GNTA could reach as high as $4.90, with a base case around $2.51 and support toward $1.32 — roughly +67% from $1.50. Buyers look set to stay in control over this stretch.
Expect GNTA to range from $1.32 to $5.25 through 2035. The $2.63 average target implies a +75% move from current prices. That is up +5% on the projected 2034 average. Momentum favours further upside here.
The GNTA price prediction for 2040 points to an average of $4.40 (low $1.98, high $9.66) — a potential gain of +193% on today's $1.50. Buyers look set to stay in control over this stretch.
In 2050, GNTA is projected to trade between $2.42 and $12.35, averaging $5.37 — a potential gain of +258% from today's $1.50. That is up +22% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in GNTA today (≈ 666.666667 GNTA) could be worth
$3,580.64
+$2,580.64 (+258%) by 2050 · US Dollar
Based on the average projected GNTA price of $5.37 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GNTAwould be worth at today's price.
$1,000 invested in GNTA on Jul 10, 2025 (≈ 256.41025 GNTA) would be worth
$384.62
-$615.38 (-61.5%) today · 0.38× · US Dollar
Based on a GNTA entry price of $3.9 vs. today's $1.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.72 | $872.09 | -12.8% |
| 1 month ago | $1.65 | $909.09 | -9.1% |
| 3 months ago | $0.669 | $2,242.15 | +124.2% |
| 6 months ago | $1.39 | $1,079.14 | +7.9% |
| 1 year ago | $3.9 | $384.62 | -61.5% |
| All time (4.6y) ago | $11 | $136.36 | -86.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GNTA forecast.
Our base-case forecast reaches $3.00 around 2040.
Implied market cap at $3.00: $144.65M
The multi-year forecast shows a gradual lift in average price from 2026 through the early 2030s, followed by stronger upside in the mid-to-late 2030s and beyond. From 2026 to 2031, the avg forecasts run from $1.53 to $1.65 with ROIs of 0% and 8%, reflecting a period of muted gains before more pronounced upside. From 2032 onward, the outlook becomes bullish, with 2032 avg $2.32 (ROI 51.6%), 2033 avg $2.76 (80.7%), 2034 avg $2.63 (72%), and 2035 avg $2.78 (81.6%).
The longer horizon shows substantial upside: 2040 avg $4.70 (ROI 207.3%) and 2050 avg $5.76 (ROI 276.4%). The sentiment also shifts to BULLISH from 2032 onward.
Tap a question to reveal the answer.
2030 forecast: min $0.9609, avg $1.55, max $2.70, ROI 1.6%, sentiment NEUTRAL.
The forecast shows mixed early years (2026–2029) with ROIs of 0%, 8.9%, 4.2%, and -7.6%, followed by stronger upside from 2032 onward, including a 2050 max of $13.25 and ROI of 276.4%. This indicates high risk and potential for substantial upside over the longer term.
Yes, according to the forecast, the 2035 max is $5.55, the 2040 max is $10.32, and the 2050 max is $13.25.
Current price is $1.53 and market cap is $36.09M.
Sentiment NEUTRAL; RSI(14) 50; SMA50 $1.27; SMA200 $1.56; support $0.597; resistance $2.20; 30-day range $1.03–$2.27; annualized volatility 100%.
Genenta Science S.p.A. Community Discussion
0Share your Genenta Science S.p.A. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.